Application Note No. 76 Development of an Assay for the COVID-19 Drug Remdesivir- Toward Proper Remdesivir Use in Patients with Pre-Existing Conditions‐ Atsushi Yonezawa 1, Eishi Imoto2, Yoshihiro Hayakawa2 Pharmaceutical Pharmaceuticals Abstract This article establishes a mass spectrometer-based analytical…
Key words
remdesivir, patients, renal, dysfunction, kyoto, nucleoside, other, approval, clinical, granted, impaired, hospital, pharmaceuticals, trials, drug